Literature DB >> 7327890

Clinical observations with Cetiprin (emepronium bromide).

A Hamvas, I Romics, F Balogh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7327890     DOI： 10.1007/bf02082058

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  6 in total

1.  Biological fate of C14-labelled ethyl (3,3-diphenyl-l-methyl-propyl) dimethylammoniumbromide Cetiprin, a monoquaternary ammonium compound.

Authors:  E HANSSON; C G SCHMITERLOW
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1961

2.  A study of cetiprin as a urologic drug.

Authors:  G JONSSON; B ZEDERFELDT
Journal:  Urol Int       Date:  1957       Impact factor: 2.089

3.  Functional bladder capacity in enuretic and nonenuretic children.

Authors:  B Starfield
Journal:  J Pediatr       Date:  1967-05       Impact factor: 4.406

4.  Emepronium bromide (Cetiprin). Its effect on bladder pressure and urinary flow in healthy subjects.

Authors:  J Boman; B von Garrelts
Journal:  Scand J Urol Nephrol       Date:  1973

5.  Emepronium bromide (Cetiprin) as a postoperative spasmolytic agent in transvesical prostatectomy.

Authors:  J H Syversen; E Mollestad; L S Semb
Journal:  Scand J Urol Nephrol       Date:  1976

6.  Clinical trial of emepronium bromide in nocturnal frequency of old age.

Authors:  J C Brocklehurst; J B Dillane; J Fry; P Armitage
Journal:  Br Med J       Date:  1969-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.